Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KAAKKOLA, Seppo")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3
Export

Selection :

  • and

Position of COMT inhibition in the treatment of Parkinson's diseaseGORDIN, Ariel; KAAKKOLA, Seppo; TERÄVÄINEN, Heikki et al.Advances in neurology. 2003, Vol 91, pp 237-250, issn 0091-3952, 14 p.Article

Strategies to modify levodopa treatmentWIDNER, Hakan.Advances in neurology. 2003, Vol 91, pp 229-236, issn 0091-3952, 8 p.Article

Differential diagnosis between early Parkinson's disease and dementia with Lewy bodiesSULKAVA, Raimo.Advances in neurology. 2003, Vol 91, pp 411-413, issn 0091-3952, 3 p.Article

Parkinson's DiseaseGORDIN, Ariel; KAAKKOLA, Seppo; TERÄVÄINEN, Heikki et al.Advances in neurology. 2003, Vol 91, issn 0091-3952, 448 p.Serial Issue

Parkinson revisited: Pathophysiology of motor signsHALLETT, Mark.Advances in neurology. 2003, Vol 91, pp 19-28, issn 0091-3952, 10 p.Article

Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein lossFURUKAWA, Yoshiaki.Advances in neurology. 2003, Vol 91, pp 401-410, issn 0091-3952, 10 p.Article

Dystonia in Parkinsonian syndromesALBANESE, Alberto.Advances in neurology. 2003, Vol 91, pp 351-360, issn 0091-3952, 10 p.Article

Overview of the genetics of ParkinsonismGASSER, Thomas.Advances in neurology. 2003, Vol 91, pp 143-152, issn 0091-3952, 10 p.Article

Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studiesTANNER, Caroline M.Advances in neurology. 2003, Vol 91, pp 133-142, issn 0091-3952, 10 p.Article

α-Synuclein and Parkinson's diseaseGOLBE, Lawrence I.Advances in neurology. 2003, Vol 91, pp 165-174, issn 0091-3952, 10 p.Article

Essential tremor and ParkinsonismRAJPUT, Alex; RAJPUT, Michele.Advances in neurology. 2003, Vol 91, pp 397-399, issn 0091-3952, 3 p.Article

Surgery for Parkinson's disease, the five W's: Why, who, what, where, and whenLOZANO, Andres M.Advances in neurology. 2003, Vol 91, pp 303-307, issn 0091-3952, 5 p.Article

Sleep disorders in Parkinson's diseaseLARSEN, Jan P.Advances in neurology. 2003, Vol 91, pp 329-334, issn 0091-3952, 6 p.Article

Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?KISH, Stephen J.Advances in neurology. 2003, Vol 91, pp 39-49, issn 0091-3952, 11 p.Article

Treatment of advanced Parkinson's disease: An evidence-based analysisGOETZ, Christopher G.Advances in neurology. 2003, Vol 91, pp 213-228, issn 0091-3952, 16 p.Article

Dopaminergic drugs in development for Parkinson's diseaseKORCZYN, Amos D.Advances in neurology. 2003, Vol 91, pp 267-271, issn 0091-3952, 5 p.Article

Treatment of dystonia in Parkinson's diseaseKING CHING TSUI, Joseph.Advances in neurology. 2003, Vol 91, pp 361-364, issn 0091-3952, 4 p.Article

Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopaSALENIUS, Stephan; AVIKAINEN, Sari; KAAKKOLA, Seppo et al.Brain. 2002, Vol 125, pp 491-500, issn 0006-8950, 3Article

The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's diseaseLYYTINEN, Jukka; SOVIJÄRVI, Anssi; KAAKKOLA, Seppo et al.Clinical neuropharmacology. 2001, Vol 24, Num 1, pp 50-57, issn 0362-5664Article

Effects of an acute D2-dopaminergic blockade on the somatosensory cortical responses in healthy humans: evidence from evoked magnetic fieldsHUTTUNEN, Juha; KÄHKÖNEN, Seppo; KAAKKOLA, Seppo et al.Neuroreport (Oxford). 2003, Vol 14, Num 12, pp 1609-1612, issn 0959-4965, 4 p.Article

NeuroregenerationSTRELAU, Jens; UNSICKER, Klaus.Advances in neurology. 2003, Vol 91, pp 95-100, issn 0091-3952, 6 p.Article

Estrogens and agingTUPPURAINEN, Marjo; SAARIKOSKI, Seppo.Advances in neurology. 2003, Vol 91, pp 101-106, issn 0091-3952, 6 p.Article

Are there clinically significant differences between dopamine agonistsSTOCCHI, Fabrizio; VACCA, Laura; ONOFRJ, Marco et al.Advances in neurology. 2003, Vol 91, pp 259-266, issn 0091-3952, 8 p.Article

Effects of scopolamine on MEG spectral power and coherence in elderly subjectsOSIPOVA, Daria; AHVENINEN, Jyrki; KAAKKOLA, Seppo et al.Clinical neurophysiology. 2003, Vol 114, Num 10, pp 1902-1907, issn 1388-2457, 6 p.Article

Preclinical versus clinical neuroprotectionGRÜNBLATT, Edna; SCHLÖSSER, Robert; GERLACH, Manfred et al.Advances in neurology. 2003, Vol 91, pp 309-328, issn 0091-3952, 20 p.Article

  • Page / 3